Northcoast Research Analysts Lower Earnings Estimates for Henry Schein Inc. (HSIC)
Henry Schein Inc. (NASDAQ:HSIC) – Stock analysts at Northcoast Research reduced their Q2 2017 earnings per share estimates for shares of Henry Schein in a report issued on Thursday. Northcoast Research analyst E. Snyder now anticipates that the brokerage will post earnings of $1.77 per share for the quarter, down from their previous estimate of $1.78. Northcoast Research also issued estimates for Henry Schein’s Q3 2017 earnings at $1.84 EPS, Q4 2017 earnings at $2.05 EPS and FY2017 earnings at $7.26 EPS.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Thursday, August 4th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.63 by $0.01. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The company earned $2.87 billion during the quarter, compared to the consensus estimate of $2.85 billion. During the same period last year, the company earned $1.46 EPS. Henry Schein’s revenue for the quarter was up 9.3% on a year-over-year basis.
A number of other equities analysts also recently issued reports on HSIC. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, July 5th. Bank of America Corp. began coverage on Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 price target on the stock. Robert W. Baird reissued an “outperform” rating and set a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday, October 4th. Finally, Goldman Sachs Group Inc. raised Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target on the stock in a research report on Tuesday, October 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $159.50.
Henry Schein (NASDAQ:HSIC) traded up 0.12% during midday trading on Monday, reaching $153.53. The company had a trading volume of 59,072 shares. The firm has a 50-day moving average of $161.57 and a 200 day moving average of $169.75. The company has a market capitalization of $12.56 billion, a P/E ratio of 26.01 and a beta of 1.05. Henry Schein has a 1-year low of $142.64 and a 1-year high of $183.00.
In other news, Director Paul Brons sold 3,381 shares of Henry Schein stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $164.03, for a total value of $554,585.43. Following the sale, the director now directly owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.27% of the company’s stock.
Several hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Henry Schein by 2.2% in the second quarter. Vanguard Group Inc. now owns 7,493,463 shares of the company’s stock worth $1,324,844,000 after buying an additional 161,065 shares in the last quarter. BlackRock Fund Advisors raised its stake in shares of Henry Schein by 2.4% in the second quarter. BlackRock Fund Advisors now owns 2,369,132 shares of the company’s stock worth $418,863,000 after buying an additional 55,384 shares in the last quarter. Janus Capital Management LLC increased its position in shares of Henry Schein by 16.5% in the second quarter. Janus Capital Management LLC now owns 2,027,848 shares of the company’s stock worth $358,522,000 after buying an additional 286,929 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Henry Schein by 55.7% in the second quarter. UBS Asset Management Americas Inc. now owns 802,401 shares of the company’s stock worth $141,865,000 after buying an additional 286,976 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Henry Schein by 4.1% in the first quarter. Geode Capital Management LLC now owns 772,565 shares of the company’s stock worth $133,135,000 after buying an additional 30,593 shares during the last quarter. 92.03% of the stock is currently owned by hedge funds and other institutional investors.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.